Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06783725 · ClinicalTrials.gov registry record · NA

Sleep Intervention and Quality of Life in Down Syndrome

A NA study of Down Syndrome and Down Syndrome (Trisomy 21), sponsored by University of Alabama at Birmingham.

Compiled by PlainTrial · August 8, 2026

Recruiting
Registry status: NA
Development phase: 20
Enrollment target: 1
Study location

NCT06783725: Recruiting NA study of Down Syndrome and Down Syndrome (Trisomy 21), sponsored by University of Alabama at Birmingham.

NCT06783725 is a NA study of Down Syndrome and Down Syndrome (Trisomy 21) that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 20 participants, below the 2,471-participant average among 54 other Down Syndrome trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06783725, a NA study of Down Syndrome and Down Syndrome (Trisomy 21), is actively recruiting participants, sponsored by University of Alabama at Birmingham.

RECRUITING
Registry status: NA
Development phase: 20 participants
Enrollment target: 1
Study location

Study Summary

Aim 1 of the proposed project will be to adapt the virtual Mindfulness-Based Therapy for Insomnia (MBTI) for individuals with Down syndrome (DS). The investigators will work closely with a community advisory board consisting of individuals with DS, their caregivers, and clinicians specializing in DS and sleep medicine to ensure that the intervention protocol is relevant and appropriate for young people with DS (age 12 and older). Planned adaptations include 1) utilization of visual aids and videos to increase engagement and reinforce mindfulness concepts and practices; 2) shortened meditation practices to accommodate concentration limits of individuals with DS; 3) caregiver involvement reflecting the important role of caregivers in daily functioning of individuals with DS; 4) adapted homework to cater to the learning styles of individuals with DS; 5) daily reminders to encourage regular practice and reinforce the importance of consistency; and 6) modified session structure to ensure that participants are able to discuss their experiences and refine their mindfulness practice. During the first 6 months of the project, the investigators will meet monthly with the community advisory board and use an iterative process to develop detailed intervention protocol for a virtual MBTI suitable for young people with DS. Aim 2 of the project will be to pilot test the efficacy of the virtual MBTI for young people with DS. In the second half of the one-year project, the investigators will conduct a pilot randomized clinical trial (RCT) of the intervention developed in Aim 1. This project will compare the effectiveness of Mindfulness Based Therapy for Insomnia (MBTI) and Brief Behavioral Therapy for Insomnia (BBTI) for young people with Down syndrome (DS). The interventions will be compared on their impact on improving sleep problems, quality of life, and functional outcomes. This project will also test if targeting the sleep of the caregiver in addition to the individual with Do

Primary Outcome

Assessed using wearable devices (FitBit Versa 4), which record sleep parameters: Sleep duration (in hours). Sleep duration in hours will be averaged over seven consecutive days, before and after the 8-week intervention. Higher scores indicate better outcome.

Conditions Studied

Down Syndrome Down Syndrome (Trisomy 21)

Interventions

BEHAVIORAL Mindfulness-Based Therapy for Insomnia
BEHAVIORAL Wait-list control

Study Locations (1)

Alabama

University of Alabama at Birmingham - Birmingham

Trial Details

Field	Value
Enrollment Target	20 participants
Start Date	2025-03-01
Est. Completion	2027-12-31
Phase	NA

University of Alabama at Birmingham

1,160 total trials

What NCT06783725 shows while recruiting

NCT06783725 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 2,471-participant average among 54 other Down Syndrome trials with a reported enrollment target (99% lower).

The record links to 2 conditions, with Down Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Mindfulness-Based Therapy for Insomnia is the first listed.

NCT06783725 reports a single indexed study location in Alabama.

Frequently Asked Questions

What is clinical trial NCT06783725 about?

NCT06783725 is a clinical study titled "Sleep Intervention and Quality of Life in Down Syndrome". Aim 1 of the proposed project will be to adapt the virtual Mindfulness-Based Therapy for Insomnia (MBTI) for individuals with Down syndrome (DS). The investigators will work closely with a community advisory board consisting of individuals with DS, their caregivers, and clinicians specializing in DS...

What is the current status of trial NCT06783725?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-03-01. Estimated completion is 2027-12-31.

What conditions does trial NCT06783725 study?

This clinical trial studies the following conditions: Down Syndrome, Down Syndrome (Trisomy 21).

What interventions are being tested in trial NCT06783725?

The interventions under investigation include: Mindfulness-Based Therapy for Insomnia (BEHAVIORAL), Wait-list control (BEHAVIORAL).

Who is sponsoring clinical trial NCT06783725?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06783725 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Down Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06783725's enrollment target sits among peer trials

20 44th of 54 higher than 9 of 54 other Down Syndrome trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Down Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06783725, the US trial registry maintained by the National Library of Medicine. NCT06783725 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.